Shoulder arthroplasty in patients with juvenile idiopathic arthritis: long-term outcomes

被引:4
|
作者
Marigi, Erick M. [1 ]
Lee, Dustin [1 ]
Marigi, Ian [1 ]
Werthel, Jean-David [2 ]
Barlow, Jonathan D. [1 ]
Sperling, John W. [1 ]
Sanchez-Sotelo, Joaquin [1 ]
Schoch, Bradley S. [3 ]
机构
[1] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA
[2] Hop Ambroise Pare, Dept Orthoped Surg, Boulogne Billancourt, France
[3] Mayo Clin, Dept Orthoped Surg, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
Juvenile idiopathic arthritis; hemiarthroplasty; anatomic total shoulder arthroplasty; reverse shoulder arthroplasty; RHEUMATOID-ARTHRITIS; RADIOGRAPHIC EVALUATION; HEMIARTHROPLASTY; REPLACEMENT;
D O I
10.1016/j.jse.2021.06.014
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatologic disease that occurs in the pediatric population. Often, JIA continues throughout life, leading to progressive polyarticular arthritis and significant joint destruction and disability, oftentimes requiring replacement surgery. This study aimed to determine the outcomes of primary shoulder arthroplasty (SA) in patients with JIA. Methods: Over a 42-year time period (1977-2019), 67 primary SA (20 hemiarthroplasty [HA], 38 anatomic total shoulder arthroplasty [TSA], and 9 reverse shoulder arthroplasty [RSA]) with a prior diagnosis of HA formally established in a multidisciplinary rheumatologic clinic met inclusion criteria. Further assessment was performed with inclusion of the visual analog scale pain score, active shoulder range of motion (ROM), imaging studies, complications, and implant survivorship free from reoperation and revision. Results: SA led to substantial improvements in pain and ROM across the entire cohort at an average follow-up period of 12.2 years (range, 2-34 years). TSA was associated with the lowest pain scores (0.8; P - .02) and the highest American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form scores (77.4; P- .04) at the most recent follow-up when compared to HA and RSA. There were 14 (21%) complications across the cohort with rotator cuff failure (n = 4; 5.9%) as the most common complication followed by infection (n = 3; 4.5%). Revision surgery was performed in 5 shoulders (7.5%), with 5-year implant survival rates of 95.1% at 5 years, 93% at 10 years, 89.4% at 20 years, and 79.5% at 30 years. At 30 years, TSA was associated with better survival (90.1%) than HA (71.8%). Conclusions: Primary shoulder arthroplasty in the form of HA, TSA, and RSA offers a reliable surgical option for JIA patients with respect to pain reduction and ROM improvements. Unique challenges still exist in this cohort, in particular younger patients with an elevated propensity for glenoid bone erosion and a complication rate of 20.9%. As such, HA may not be ideal in this patient population. However, despite rotator cuff and glenoid concerns, TSA seems to be associated with better pain relief and patient-reported outcomes with the most durability in the long term when compared to HA. (C) 2021 Journal of Shoulder and Elbow Surgery Board of Trustees. All rights reserved.
引用
收藏
页码:2703 / 2710
页数:8
相关论文
共 50 条
  • [31] SAFETY PROFILE OF ETANERCEPT IN LONG-TERM USE IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS (JIA)
    Klotsche, Jens
    Klein, Ariane
    Niewerth, Martina
    Ganser, Gerd
    Aries, Peer
    Walther, Marisa
    Haas, Peter
    Keysser, Gernot
    Horneff, Gerd
    Minden, Kirsten
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 102 - 102
  • [32] Therapy Survival and Long-Term Safety of Etanercept in Patients with juvenile idiopathic Arthritis (JIA)
    Klotsche, J.
    Niewerth, M.
    Weber, K.
    Hammer, M.
    Haas, J.
    Horneff, G.
    Minden, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 92 - 93
  • [33] Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis
    Claxton, Matthew R.
    Wagner, Eric R.
    Rizzo, Marco
    HAND-AMERICAN ASSOCIATION FOR HAND SURGERY, 2022, 17 (02): : 271 - 277
  • [34] LONG-TERM FOLLOW-UP OF PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS IN A MEXICAN CENTER
    Fortuna, Brenda
    Ochoa-Alderete, Lucero
    Guerra, Fernando
    Garcia-Rodriguez, Fernando
    Torres, Daniela
    Villarreal-Trevino, Ana
    De la O-Cavazos, Manuel E.
    Rubio, Nadina
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1951 - 1951
  • [35] LONG-TERM IMPACT OF JUVENILE IDIOPATHIC ARTHRITIS ON QUALITY OF LIFE OF ADULT PATIENTS IN GREECE
    Paskalis, G. C.
    Dimopoulou, D.
    Trachana, M.
    Theocharidou, C. C.
    Pratsidou-Gertsi, P.
    Oikonomou, T.
    Dimitroulas, T.
    Garyfallos, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1656 - 1657
  • [36] Early Self-Reported Pain in Juvenile Idiopathic Arthritis as Related to Long-Term Outcomes: Results From the Nordic Juvenile Idiopathic Arthritis Cohort Study
    Arnstad, Ellen Dalen
    Rypdal, Veronika
    Peltoniemi, Suvi
    Herlin, Troels
    Berntson, Lillemor
    Fasth, Anders
    Nielsen, Susan
    Glerup, Mia
    Ekelund, Maria
    Zak, Marek
    Aalto, Kristiina
    Nordal, Ellen
    Romundstad, Pal Richard
    Rygg, Marite
    Marhaug, Gudmund
    Anderson-Gare, Boel
    Pedersen, Freddy Karup
    Lahdenne, Pekka
    Pelkonen, Pirkko
    ARTHRITIS CARE & RESEARCH, 2019, 71 (07) : 961 - 969
  • [37] Long-term outcomes in Juvenile Myositis patients
    Tsaltskan, Vladislav
    Aldous, Annette
    Serafi, Sam
    Yakovleva, Anna
    Sami, Heidi
    Mamyrova, Gulnara
    Targoff, Ira N.
    Schiffenbauer, Adam
    Miller, Frederick W.
    Simmens, Samuel J.
    Curiel, Rodolfo
    Jones, Olcay Y.
    Rider, Lisa G.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (01) : 149 - 155
  • [38] Long-Term Safety and Efficacy of Abatacept in Children With Juvenile Idiopathic Arthritis
    Ruperto, Nicolino
    Lovell, Daniel J.
    Quartier, Pierre
    Paz, Eliana
    Rubio-Perez, Nadina
    Silva, Clovis A.
    Abud-Mendoza, Carlos
    Burgos-Vargas, Ruben
    Gerloni, Valeria
    Melo-Gomes, Jose A.
    Saad-Magalhaes, Claudia
    Chavez-Corrales, J.
    Huemer, Christian
    Kivitz, Alan
    Blanco, Francisco J.
    Foeldvari, Ivan
    Hofer, Michael
    Horneff, Gerd
    Huppertz, Hans-Iko
    Job-Deslandre, Chantal
    Loy, Anna
    Minden, Kirsten
    Punaro, Marilynn
    Flores Nunez, Alejandro
    Sigal, Leonard H.
    Block, Alan J.
    Nys, Marleen
    Martini, Alberto
    Giannini, Edward H.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (06): : 1792 - 1802
  • [39] Long-term safety and efficacy of tocilizumab in patients with systemic juvenile idiopathic arthritis (JIA) under the extension and long-term trials
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Miyamae, Takako
    Mori, Masaaki
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S631 - S632
  • [40] THE LONG TERM OUTCOME OF JUVENILE IDIOPATHIC ARTHRITIS
    Ravelli, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 32 - 32